ANRO (Alto Neuroscience) Effective Interest Rate on Debt %: 9.24% (As of Mar. 2026)


ANRO Alto Neuroscience Inc ANRO
12 GF Score
Price $24.73
! 2 Warning Signs
View Full Analysis

What is Alto Neuroscience Effective Interest Rate on Debt %?

Alto Neuroscience ANRO -3.77% 12 Effective Interest Rate on Debt % is 9.24% as of Mar. 2026. GuruFocus rates ANRO with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Alto Neuroscience's annualized positive value of Interest Expense for the quarter that ended in Mar. 2026 was $2.18 Mil. Alto Neuroscience's average total debt for the quarter that ended in Mar. 2026 was $23.59 Mil. Therefore, Alto Neuroscience's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2026 was 9.24%.

Alto Neuroscience  (NYSE:ANRO) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Alto Neuroscience Effective Interest Rate on Debt % Related Terms

Alto Neuroscience Effective Interest Rate on Debt % Historical Data

* Premium members only.

The historical data trend for Alto Neuroscience's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alto Neuroscience Effective Interest Rate on Debt % Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Effective Interest Rate on Debt %
0.00 0.00 13.88 10.21 12.07

Alto Neuroscience Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.03 9.62 9.48 8.94 9.24

ANRO vs SANA, AVTX, REPL: Effective Interest Rate on Debt % Comparison

For the Biotechnology subindustry, Alto Neuroscience's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alto Neuroscience Effective Interest Rate on Debt % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alto Neuroscience's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Alto Neuroscience's Effective Interest Rate on Debt % falls into.


ANRO
12GF Score
Alto Neuroscience Inc ANRO
Effective Interest Rate on Debt % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alto Neuroscience Effective Interest Rate on Debt % Calculation

Alto Neuroscience's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2025 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2024 )+Total Debt  (A: Dec. 2025 ))/ count )
=-1  *  -2.469/( (16.944+23.958)/ 2 )
=-1  *  -2.469/20.451
=12.07 %

where

Total Debt  (A: Dec. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=16.074 + 0.87
=16.944

Total Debt  (A: Dec. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=22.222 + 1.736
=23.958

Alto Neuroscience's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2026 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Dec. 2025 )+Total Debt  (Q: Mar. 2026 ))/ count )
=-1  *  -2.18/( (23.958+23.215)/ 2 )
=-1  *  -2.18/23.5865
=9.24 %

where

Total Debt  (Q: Dec. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=22.222 + 1.736
=23.958

Total Debt  (Q: Mar. 2026 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=19.775 + 3.44
=23.215

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2026) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

What does a Effective Interest Rate on Debt % of 9.24% mean?
Alto Neuroscience (ANRO) has a Effective Interest Rate on Debt % of 9.24% as of Mar. 2026. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Alto Neuroscience and its competitors.
Is Alto Neuroscience's Effective Interest Rate on Debt % too high?
Alto Neuroscience's current Effective Interest Rate on Debt % is 9.24%. Overall, Alto Neuroscience has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Alto Neuroscience's Effective Interest Rate on Debt % compare to SANA and AVTX?
Alto Neuroscience's Effective Interest Rate on Debt % of 9.24% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effective Interest Rate on Debt % for a Biotechnology company?
A good Effective Interest Rate on Debt % depends on the Biotechnology industry context. However, Effective Interest Rate on Debt % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effective Interest Rate on Debt % mean?
A high Effective Interest Rate on Debt % can signal that a stock is expensive relative to its fundamentals. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Alto Neuroscience and its competitors. Alto Neuroscience's current Effective Interest Rate on Debt % is 9.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alto Neuroscience stock overvalued right now?
Alto Neuroscience (ANRO) has a current Effective Interest Rate on Debt % of 9.24%. The current Effective Interest Rate on Debt % is 9.24%. Alto Neuroscience's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effective Interest Rate on Debt % calculated?
Effective Interest Rate on Debt % is calculated from a company's financial statements. For Alto Neuroscience (ANRO), the current Effective Interest Rate on Debt % is 9.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alto Neuroscience Business Description

Address 650 Castro Street, Suite 450, Mountain View, CA, USA, 94041
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
12GF Score

Get the complete analysis for ANRO

Effective Interest Rate on Debt % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.73
Price